Clinical Trials Browser

Has results × Breast Neoplasms, Male × Erlotinib Hydrochloride × Clear all

NCT00834678 2018-04-17

Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Phase 1/2 Completed

11 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00054275 2016-02-17

Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer

Phase 2 Completed

39 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male